发明申请
US20090264634A1 SEQUENCES CHARACTERISTIC OF HYPOXIA-REGULATED GENE TRANSCRIPTION
审中-公开
HYPOXIA调控基因转录的序列特征
- 专利标题: SEQUENCES CHARACTERISTIC OF HYPOXIA-REGULATED GENE TRANSCRIPTION
- 专利标题(中): HYPOXIA调控基因转录的序列特征
-
申请号: US12269722申请日: 2008-11-12
-
公开(公告)号: US20090264634A1公开(公告)日: 2009-10-22
- 发明人: Paz EINAT , Rami Skaliter , Elena Feinstein , Aviv Regev , Hagar Ralinski
- 申请人: Paz EINAT , Rami Skaliter , Elena Feinstein , Aviv Regev , Hagar Ralinski
- 申请人地址: US CA Fremont
- 专利权人: Quark Pharmaceuticals, Inc.
- 当前专利权人: Quark Pharmaceuticals, Inc.
- 当前专利权人地址: US CA Fremont
- 主分类号: C07H21/04
- IPC分类号: C07H21/04
摘要:
There are provided polynucleotides that are modulated by hypoxic conditions. The disclosure includes such genes and proteins as well as analogs, salts and functional derivatives of such proteins, and DNA encoding such analogs, and methods of use. Methods for treating the effects of stroke, hypoxia and/or ischemia by regulating such genes or proteins are also disclosed. The presence of hypoxia or a hypoxia-associated pathology may be diagnosed by screening for the presence of at least one polynucleotide having the nucleic acid sequence according to the present invention. Methods of regulating hypoxia associated pathologies are also provided.
信息查询